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AKTIVITI ANTIBAKTERIA BAGI EUPHORBIA HIRTA (L.): 
EUPHORBIACEAE DAN PEMENCILAN JUZUK BIOAKTIFNYA 
 
ABSTRAK 
 
 Produk semulajadi, terutamanya tumbuhan ubatan, kekal sebagai sumber 
berharga sebagai pendekatan revolusi hijau dalam penemuan sebatian antibakteria 
novel. Tumbuhan Euphorbia hirta (L.) digunakan secara tradisional di negara-negara 
tropika untuk rawatan gastrousus, bronkial dan penyakit pernafasan yang disebabkan 
oleh agen jangkitan nosokomial. Dalam kajian ini, pelbagai ekstrak pelarut (metanol, 
etanol, etil asetat, diklorometana dan heksana) daripada tumbuhan E. hirta telah dikaji 
dalam penyaringan fitokimia untuk menentukan jumlah kandungan fenolik dan 
flavonoid. Aktiviti antibakteria yang berpotensi daripada ekstrak mentah dinilai 
melalui ujian in vitro antibakteria dengan menggunakan kaedah mikropencairan 
medium brot terhadap panel patogen klinikal yang rintang dan strain jenis kultur 
koleksi Amerika (ATCC). Ekstrak yang paling bioaktif, ekstrak metanol,  
kemudiannya menjalani penulenan dengan kaedah fraksinasi dan pemencilan 
berdasarkan bioaktiviti menggunakan kromatografi turus, yang akhirnya menghasilkan 
tiga sebatian tulen antibakteria. Struktur kimia sebatian tulen telah dikenalpasti melalui 
kaedah analisis spektroskopi. Setiap sebatian antibakteria yang telah dipencilkan ini 
dikaji dalam mekanisme tindakan antibakterianya melalui beberapa manifestasi 
fisiologi bakteria yang melibatkan ketelapan membran luar, pengeluaran ion kalium 
intraselular, kebocoran nukleotida intraselular dan pengubahan morfologi sel bakteria. 
Kesan gabungan sebatian-sebatian antibakteria terpencil daripada E. hirta dengan ejen 
 xxii 
 
antibakteria klinikal, cefepim, telah dinilai melalui kaedah “checkerboard” 
micropencairan medium brot. Ekstrak mentah metanol E. hirta memperolehi peratusan 
hasil tertinggi (12.5 %) bagi jumlah kandungan fenolik 213.4 ± 0.75 mg GAE/g 
ekstrak dan jumlah kandungan flavanoid 62.3 ± 1.01 mg CE/g ekstrak. Kajian ini 
memperlihatkan aktiviti antibakteria yang sangat ketara bagi ekstrak mentah metanol 
terhadap isolat klinikal Pseudomonas aeruginosa yang rintang, dengan nilai MIC dan 
MBC sebanyak 0.063 mg/mL and 0.125 mg/mL masing-masing. Fraksinasi dan 
pemencilan  ekstrak  mentah metanol selanjutnya telah mengeluarkan tiga sebatian 
antibakteria yang dikenalpasti sebagai asid kafeik (CA), epikatechin 3-gallat (ECG) 
dan quersitrin. ECG telah mempamerkan aktiviti anti-jangkitan yang paling 
menggalakkan terhadap P. aeruginosa dengan kesan potensi yang sama seperti 
kawalan positif, cefepim, pada nilai MIC dan MBC sebanyak 16 μg/mL dan 31 μg/ 
mL. CA kurang aktif daripada ECG dengan nilai MIC dan MBC yang rendah sebanyak 
dua kali ganda diikuti dengan quersitrin yang menunjukkan keberkesanan yang sama 
dengan ekstrak mentah metanol. ECG dipencilkan daripada E. hirta buat pertama 
kalinya dalam kajian ini manakala CA dan quersitrin dilaporkan buat kali pertama 
untuk aktiviti antibakteria terhadap P. aeruginosa. Kajian mekanisme tindakan 
menunjukkan kedua-dua ECG dan CA mempunyai kesan bakterisidal manakala 
quersitrin mempamer kesan bakteriostatik terhadap P. aeruginosa. ECG dan CA 
masing-masing berkemampuan untuk mengganggu membran luar dan membran 
sitoplasma sel P. aeruginosa melalui peningkatan ketelapan sel membran. Mikrograf 
pengimbas elektron menunjukkan ECG dan CA menyebabkan kerosakan ketara pada 
sel membran dan kebocoran kandungan sitoplasma yang membawa kepada kematian 
sel. Sebagai langkah untuk memaksimumkan lagi kesan antibakteria, suatu kombinasi 
 xxiii 
 
cefepim dengan ECG, CA dan quersitrin masing-masing telah diuji secara individu 
terhadap isolat P. aeruginosa. Cefepime digabungkan dengan ECG telah menghasilkan 
kesan sinergistik dengan purata indeks FIC sebanyak 0.24. Walau bagaimanapun, 
gabungan cefepim dengan CA menunjukkan kesan interaksi penambah dan gabungan 
cefepim dengan quersitrin pula memaparkan kesan berkecuali. Sebagai kesimpulan, 
juzuk antibakteria yang telah dipencilkan daripada tumbuhan ubatan E. hirta 
mempunyai potensi anti-jangkitan yang menonjol terhadap patogen resistan P. 
aeruginosa. Molekul bioaktif yang bersifat klinikal ini menanti pemajuan selanjutnya 
sebagai ejen kemoterapeutik yang baru. 
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ANTIBACTERIAL ACTIVITY OF EUPHORBIA HIRTA (L.): 
EUPHORBIACEAE AND ISOLATION OF ITS BIOACTIVE CONSTITUENTS 
 
ABSTRACT 
 
 Natural products, especially medicinal plants, remain as a valuable source 
offering a revolutionary green approach to the discovery of novel antibacterial 
compounds. Euphorbia hirta (L.) plant is traditionally used in many tropical countries 
for the treatment of gastrointestinal, bronchial and respiratory ailments caused by 
nosocomial infectious agents.  In this study, various solvent extracts (methanol, 
ethanol, ethyl acetate, dichloromethane and hexane) of E.  hirta were subjected to 
phytochemical screening to determine total phenolic and flavonoid contents. The 
potential antibacterial activities of the crude extracts were assessed via in vitro 
antibacterial test using broth microdilution method against a panel of clinically 
resistant pathogens and American Type Culture Collection (ATCC) strains. The most 
bioactive extract, the methanol extract was further purified in a bioactivity-guided 
fractionation and isolation method using column chromatography, which finally 
yielded three pure antibacterial compounds. The chemical structures of these purified 
compounds were characterized and identified through analyses of spectroscopic 
methods. The isolated antibacterial constituents were investigated for the antibacterial 
mechanisms by several bacterial physiological manifestations involving outer 
membrane permeabilization, intracellular potassium ion efflux, intracellular nucleotide 
leakage and alteration of bacterial cell morphology. The combination effects of 
isolated antibacterial compounds from E. hirta with clinically established antibacterial 
 xxv 
 
agent, cefepime were evaluated via checkerboard broth microdilution method. The 
crude methanol extract of E. hirta obtained the highest percentage yield (12.5 %) with 
total phenolic content of 213.4 ± 0.75 mg GAE/g extract and total flavonoid contents 
of 62.3 ± 1.01 mg CE/g extract. This study observed remarkable antibacterial activity 
of the crude methanol extract against the resistant clinical isolate of Pseudomonas 
aeruginosa with minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) values of 0.063 mg/mL and 0.125 mg/mL. Further fractionation 
and isolation of the crude methanol extract  produced three antibacterial compounds 
which were identified as caffeic acid (CA), epicatechin 3-gallate (ECG) and quercitrin. 
ECG had displayed the most promising anti-infective activity against P. aeruginosa 
with similar potency as positive control, cefepime with MIC and MBC values of 16 
µg/mL and 31 µg/mL respectively. CA was less active than ECG, at two fold lower 
MIC and MBC values followed by quercitrin which showed the same efficacy as the 
crude methanol extract. ECG is being isolated from E. hirta for the first time in this 
study while CA and quercitrin are reported for the first time as having antibacterial 
activity against P. aeruginosa. Study on the mechanism of action showed both ECG 
and CA possessed bactericidal effect whereas quercitrin exerted bacteriostatic effect 
against P. aeruginosa.  ECG and CA were capable in disrupting the outer membrane 
and cytoplasmic membrane of P. aeruginosa cell by enhancing the cell membrane 
permeability. Scanning electron micrographs showed ECG and CA each caused 
apparent cell membrane damages and leakages of cytoplasmic contents had eventually 
led to cell death. In an attempt to further maximize antibacterial potency, combinations 
of cefepime with ECG, CA and quercitrin respectively were tested individually against 
P. aeruginosa isolate. Cefepime combined with ECG had produced synergistic effect 
 xxvi 
 
with average FIC index of 0.24. However, combination of cefepime and CA showed 
additive interaction while combination of cefepime and quercitrin displayed 
indifference effect. To conclude, antibacterial constituents isolated from the 
ethnomedicinal plant E. hirta, possessed remarkable anti-infective effect against 
resistant P. aeruginosa pathogen. These bioactive molecules of clinical value await 
further development as a new chemotherapeutic agent. 
 
1 
 
CHAPTER ONE 
LITERATURE REVIEW 
 
1.1   Medicinal plant 
Ever since the advent of humanity on earth, plants have served as unlimited source of 
phytotherapeuticals for various diseases (Clardy and Walsh, 2004). Medicinal plant 
is any plant used to prevent, ease or cure a disease or any plant utilized as a source of 
drugs or their precursors (Kotze and Eloff, 2002). Plant derived medicines have been 
of great influence to human health and well-being. According to the World Health 
Organization, 80 % of the world population depends primarily on traditional 
medicines and therapy which involves the consumption of plant extracts or their 
active constituents (WHO, 1993). 
 
Since 1978, The World Health Organization (WHO) and dozens of collaborating 
institution worldwide have sought to assess the value and extent of the use of plants 
in health care systems. Observing traditional, historic, folkloric, or ethnobotanical 
uses of plants are regarded as a useful approach for targeting research leads in the 
development of new drugs from plants. A recent survey of medicinal plants used in 
therapy worldwide found that 119 distinct chemical substances derived from 91 
species are used as drugs in one or more countries (Mahomoodally, 2013). Of these 
plant-derived substances, 74 % were discovered following chemical studies to 
determine the active compounds responsible for the use of the plant in traditional 
medicine. While many traditional uses may not be validated as safe or efficacious by 
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current scientific methodology, they can provide valuable leads for new drug 
compounds or expanded utilization in the future. 
 
1.2   Phytochemicals 
Phytochemicals are known as plant secondary metabolites which evolve naturally in 
plants. Secondary metabolites are organic compounds that are not found in all 
species of plant cells. Unlike primary metabolites, they are not essential to sustain 
growth, development, reproduction or survival of an organism. According to Edeoga 
et al. (2005), secondary metabolites are synthesized to enhance the strength of the 
plant and play an important role in deterrence against predators and pathogens. 
Secondary metabolites often play an important role in plant defence against 
herbivorous and other interspecies defences (Samuni-Blank et al., 2012). Humans 
use secondary metabolites as medicines, flavorings, and recreational drugs. Plants 
phytochemicals have been classified in several categories including alkaloids, 
terpenoids, polyphenols, flavonoids, tannins and glycosides (Kennedy and Wightman 
2005). Majority of secondary metabolites such as terpenoids, phenolics, alkaloids 
and tannins are of potential medicinal interest in drug discovery (Cowan, 1999). For 
example, aspirin was produced synthetically inspired from anti-pyretic effect of 
salicin found in the bark of the white willow tree. 
 
1.3   Medicinal plants and antimicrobial properties 
Plants products have been used since ancient time for medicinal reasons to cure and 
prevent diseases. Traditional herbal practitioners have extensively used plants to 
prevent or treat infectious conditions. However, since the launch of antibiotics in the 
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1950s from microorganism source, the use of plants as antimicrobial has been 
diminished. Annually, two or three antibiotics on average derived from 
microorganisms are being launched (Nikaido, 2009). In recent decades, the effective 
life span of any antibiotic has become limited due to misuse and abuse of antibiotics. 
Increased resistance of many microorganisms toward established drugs has made 
investigation of chemical compounds within traditional plants a necessity. 
Discovering new anti-infective agents particularly from plant sources has gained 
recognition again in the 1980s (David and Gorgon, 2012). 
 
According to Borris (1996), there are an estimated of 250,000 to 500,000 plant 
species on earth and only one-tenth of these plants had been explored. Infectious 
diseases caused by pathogen are a problem yet to be controlled adequately, which 
necessitates the exploration of alternative sources of safe, effective and acceptable 
natural antibacterial. Plants enclose immeasurable phytoconstituents and are precious 
sources of novel compounds possessing antibacterial properties. For example, 
cranberry juice (Vaccinium macrocarpon), garlic (Allium sativum), tee tree 
(Melaleuca alternifolia) and lemon balm (Melissa officinalis) are depicted as broad-
spectrum antimicrobial agents (Heinrich et al., 2004). Plant extracts as source of 
either standardized extracts or pure compounds provides unlimited possibilities to 
inhibit and eradicate bacterial growth owing to their diverse phytochemicals. 
Medicinal use of the various plant extracts vary significantly depending on the 
potency and quantity of bioactive constituents comprised in it. Medicinal plants 
possess both potential antimicrobial crude drugs as well as a source for natural 
compounds that act as new anti-infective agents in the future. 
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1.4     Major classes of antibacterial phytocompounds  
Various types of medicinal plants possessing significant antibacterial properties with 
correlative phytoconstituents are as shown in Table 1.1. Structures of common 
antibacterial plant phytochemicals are as depicted in Figure 1.1. 
 
1.4.1   Phenolics and polyphenols 
Simple phenols and phenolic acids - Cinnamic and caffeic acids are simple phenols 
consist of a single substituted phenolic ring. Both compounds were reported effective 
against bacteria (Brantner et al., 1996). Catechol and pyrogallol are hydroxylated 
phenols with two and three −OH groups each, respectively. Some authors have found 
that more number of hydroxyl groups on the phenol ring can contribute higher 
inhibitory effect to the bacteria (Scalbert, 1991; Filomena et al., 2013). Eugenol 
belongs to essential oils group possessing a C3 side chain containing no oxygen as in 
penicillin and therefore contemplated having bacteriostatic action against bacteria 
(Rastogi et al., 2008). 
 
Flavones, flavonoids, and flavonols - Flavones originated from phenolic structures 
with one carbonyl group. The inclusion of a 3-hydroxyl group produces a flavonol. 
Flavonoids on the other hand, contain hydroxylated phenolic substances at C6-C3 unit 
linked to an aromatic ring. They are known to be effective as antimicrobial 
substances against a wide array of microorganisms. Catechin belongs to the group of 
flavan-3-ols. Catechins extracted from teas were reported to have antibacterial 
activities (Friedman et al., 2006). Phloretin, isoflavone and galangin were also 
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observed for antibacterial activities against a wide range of Gram-positive and Gram-
negative bacteria (Manner et al., 2013). 
 
Quinones - Quinones derived from aromatic compounds with two ketone 
substitutions. Quinones react with microbial cell surface-exposed adhesins, cell wall 
polypeptides and membrane-bound enzymes. It also causes bacteria inaccessible to 
the substrate (Alam, 2009). 
 
Tannins - Tannin is a group of polymeric phenolic substances. Tannin is separated 
into two groups, hydrolysable and condensed tannins. Hydrolysable tannins are 
multiple esters with d-glucose such as gallic acid, while condensed tannins are 
derived from flavonoid monomers. Tannins are known to inhibit bacteria by 
deactivating the microbial enzymes and proteins and form composite with 
polysaccharide (Frutos et al., 2004). 
 
Coumarins - Coumarins belong to benzopyrone chemical class. Rehman et al. 
(2005) found in vitro antibacterial activity from group of coumarins. 
Hydroxycinnamic acid, associated to coumarins was observed to inhibit the growth 
of Gram-positive bacteria (Cheung et al., 2014). 
 
1.4.2   Terpenoids and essential oils 
These compounds are based on an isoprene structure. The general molecular formula 
of a terpene is C10H16. Terpenes exist as diterpenes (C20), triterpenes (C30), 
tetraterpenes (C40), hemiterpenes (C5) and sesquiterpenes (C15). Terpenoid 
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compounds comprise oxygen as additional element and share their derivation with 
fatty acids. Many authors have reported the antibacterial activities of terpenenes and 
terpenoids (Verica et al., 2014; Barre et al., 1997; Scortichini et al., 1991). 
 
1.4.3   Alkaloids  
Alkaloids are heterocyclic nitrogen-containing compounds. Omulokoli et al. (1997) 
had observed that diterpenoid alkaloids from the plants of Ranunculaceae family 
possessed effective antimicrobial properties. Glycoalkaloids also have been 
witnessed to have microbiocidal effects against intestinal infections (McDevitt et al., 
1996; Ghoshal et al., 1996). Berberine had been found as effective antimicrobial 
agent with its mode of action attributed to the ability to intercalate with microbial 
DNA (Phillipson and O’Neill, 1987). 
 
1.4.4   Lectins and polypeptides 
Peptides are positively charged compounds and contain disulfide bonds. Thionins are 
peptides found in barley and wheat which have been observed to be toxic to Gram-
negative and Gram-positive bacteria (Pelegrini and Franco, 2005). Fabatin, from fava 
beans appeared to inhibit E. coli and P. aeruginosa (Zhang and Lewis, 1997).  
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    Table 1.1  Plants containing antibacterial activity and its corresponding       
            phytocompounds. 
Plant Compound  Class 
  
 
  
Pimenta dioica Eugenol Terpenoid 
Aloe vera Latex Complex mixture 
Malus sylvestris Phloretin Flavonoid derivative 
Withania somniferum Withafarin A Lactone 
Berberis vulgaris Berberine Alkaloid 
Piper nigrum Piperine Alkaloid 
Anacardium pulsatilla Salicylic acids Polyphenols 
Matricaria chamomilla Anthemic acid Phenolic acid 
Capsicum annuum Capsaicin Terpenoid 
Syzygium aromaticum Eugenol Terpenoid 
Erythroxylum coca Cocaine Alkaloid 
Eucalyptus globulus Tannin Polyphenol 
Allium sativum Allicin, ajoene Sulfoxide 
Camellia sinensis Catechin Flavonoid 
Lawsonia inermis Gallic acid Phenolic 
Allium cepa Allicin Sulfoxide 
Satureja montana Carvacrol Terpenoid 
Thymus vulgaris Caffeic acid Phenolic acid 
Curcuma longa Curcumin Terpenoids 
Gaultheria procumbens Tannins Polyphenols 
 
    (Adapted and modified from Duke, 1985) 
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      Figure 1.1   Structures of common antibacterial plant phytochemicals. Adapted  
      from Cowan (1999). 
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1.5    Medicinal plant selection for drug discovery 
The main objective of using ethnomedicinal plants as sources of therapeutic agent 
are to isolate biologically active compounds for direct use as drugs, for example  
morphine, taxol, vincristine and vinblastine. The medicinal plants are also exploited 
to create novel lead bioactive compounds of known molecular structures for further 
modification in semisynthesis. These new modified molecular structures harvest 
patentable constituents with higher desirable biological activities and lower or nil 
toxicological activity, for instance metformin, verapamil, nabilone and oxycodon. 
These ethnomedicinal plant extracts are also consumed for herbal remedy, as 
example cranberry, feverfew and ginkgo biloba (Farnsworth et al., 1985). 
 
According to Verpoorte (2000), there are a few approaches available for selecting 
plants as lead drugs.  Firstly, the plants can be selected randomly followed by 
chemical screening. This approach is also known as phytochemical screening and has 
been exercised in the past and at present practised mainly in developing countries. 
The tests are carried out to detect the presence of important phytocompounds like 
alkaloids, flavonoids, iridoids and cardenolides. Although the tests are simple to 
perform, more often false-positive and false-negative tests provide results that are 
difficult to assess. It can also pose complexity to establish relationship between 
specific class of phytochemical to particular biological target (Fabricant and 
Farnsworth, 2001). 
 
The second approach involves random selection of plants followed by biological 
assay. Plant extracts are evaluated for several biological activities, including 
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antibacterial, antifungal, antidiabetic, antitumor, antifertility, anti-inflammatory, 
antihypercholesteremic, cytotocixity and others. However, no medically useful active 
compounds for human use have been developed from this approach even though 
substantial number of known and novel bioactive compounds were isolated from the 
active plants (Wall and Wani, 1996). 
 
Follow-up of biological activity report is another consideration opted for plant 
selection to facilitate drug discovery. The reports that showed plant extracts with 
remarkable pharmacological activities will be sensible to investigate and study for 
their responsible active principles. A further approach is the follow-up of 
ethnomedical uses of plants. There are a number of  ethnomedicinal information 
available in this method and among them is plants used in traditional medical system 
such as Ayurveda, Unani, Kampo and traditional Chinese medicine. These traditional 
medical systems have existed and are in use for thousands of years. They are 
frequently seen as a revised body of written knowledge and theory. These medical 
systems are being practiced till today because of their organizational strengths which 
concentrate mainly on multi-component mixtures of the plant extracts (Kinghorn, 
1994). However, these system lacks credibility owing to poor documentation of 
adverse effects of those widely used plants. In addition, the efficacy of the plant 
mixtures often poses difficulty to be assessed by Western scientific methods. 
  
Folklore, herbalism and shamanism are novice medical system where information is 
passed to the next generation through a herbalist or shaman. In this system, trivial 
information about the plant is recorded as they are often kept secret by the healers. 
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The herbalist or shaman playing the roles of pharmacist and medical doctor 
combines the spiritual, religious and cultural beliefs to treat patients, where  
treatments are often regarded as mysticism or magic. Such medical system is well 
known in Africa and South America (Bonet et al., 1999). In this type of screening 
method based on biological activity report, plant selection for potential drug 
discovery can also be accomplished through books on medical botany and herbals, 
review articles, field work reports and computer databases search (Siddique et al., 
2000). 
 
1.6  Natural product isolation 
Natural product research with regards to the isolation of novel biactive constituents 
has captured massive interest of many reserachers since exceptional developments in 
areas of chemical separation and purification methods, spectroscopic techniques and 
sensitive bioassays (Sticher, 2008). The conventional methods of isolation of natural 
products such as medicinal plants usually begins with identification, collection and 
preparation of the biological material by drying. Next, extraction can be proceeded 
with various extraction solvent systems of low to high polarity. The solvent 
extraction methods include maceration, soxhlet extraction, percolation, ultrasound-
assisted and turbo-assisted extraction. Maceration can be done at room temperature 
by immersing the plant material with the extracting solvent. Even though this method 
undergo long extraction times and high solvent consumption, it has the advantage of 
mild extraction conditions with high extraction yields (Seidel, 2012). 
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Extraction methods are applied as pre-purification step to selectively remove 
interfering components in isolation process. Pre-purification procedures can involve 
filtration, precipitation, removal selectively of chlorophyll, tannins or waxes from 
plant extacts by the use of solid-phase extraction (SPE) cartridges. Pre-packed SPE 
cartridges function by the principle of a liquid-solid extraction where the interfering 
matrix substances of a sample are retained on the solid sorbent of the cartridge while 
the components of interest are eluted as eluent or the components of interest are 
retained on the solid sorbent while the interfering matrix substances are eluted out  
(Sarker et al., 2006).  
 
Liquid-solid separation techniques are the most widely performed separation in 
liquid chromatography. This technique materializes in the forms of planar 
chromatography and column chromatography. Planar chromatography techniques 
include thin-layer chromatography (TLC) and preparative thin-layer chromatography 
(PTLC) where mobile phase is eluted through a stationary phase by capillary forces. 
The common adsorbent of TLC and PTLC is silica gel and has been utilized for the 
separation of both lipophilic and hydrophilic substance mixtures. As for the final 
purification step, gel filtration on Sephadex LH-20 is highly advised to remove 
binders or fluorescent indicators which may be extracted together with the scraped 
off compounds (Peng et al., 2006). 
 
Column chromatography is usually used for preparative separations of extract. In this 
method, a glass column is occupied and packed with an adsorbent material of defined 
particle size. The principle of the column chromatography is that when a sample 
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mixture to be separated is introduced together with the eluted mobile phase from the 
top of the column, the individual components of the mixture is partitioned between 
the solid sorbent phase and the solvent phase. Thus based on the respective 
components polarity, the individual components migrate at respective different and 
specific rates. Those substances with lower affinity and little adsorption to stationary 
phase migrate faster and eluted out first while those with strong adsorption affinity 
travel slower and eluted out last. Column chromatography can offer a rapid 
preliminary fractionation of complex mixtures (Fulzele and Satdive, 2005). 
 
Bioactivity-guided isolation technique is frequently employed to significantly reduce 
the time for hit discovery. This approach typically links information on the chemical 
profiles of extracts and fractions with their respective activity data of in vitro 
bioassays. Completing isolation of a pure substance, chemical structure elucidation 
needs to be addressed using chemical identification and characterization techniques 
such as ultra-violet and visible (UV-Vis) spectroscopy, Fourier transform infra-red 
(FTIR) spectroscopy and nuclear magnetic resonance (NMR). 
 
1.7   Bacteria  
Bacteria are single celled living things. They live in every climate and location on 
earth. These unicellular microorganisms are known as prokaryotes that without a 
nucleus or membrane bound organelles. The genetic material in a prokaryote is 
contained within a DNA-protein complex called nucleoid. In addition, prokaryotes 
also have circular DNA structures termed as plasmids which often contains 
beneficial genes. Prokaryote cells exist in five basic shapes; spherical (cocci), rod 
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(bacilli), spiral (spirilla), comma (vibrios) or corkscrew (spirochaetes). Bacteria 
reproduce through asexual reproduction usually by binary fission where a single cell, 
divides into two identical daughter cells.  
 
Bacteria are distinguished into two classes, Gram-positives and Gram-negatives 
which derived from the reaction of bacterial cells to the Gram stain. Gram staining is 
a bacteriological laboratory technique
 
used to differentiate bacteria by the physical 
properties of their cell walls (Ryan and Ray, 2004). Gram-positive and Gram-
negative bacteria have very distinct external structures. Gram-positive bacteria 
possess multilayered cell wall consisting of peptidoglycan whereas Gram-negative 
bacteria have only few layers of peptidoglycan. However, Gram-negative bacteria 
have an outer membrane external to the peptidoglycan which is mainly containing 
lipopolysaccharides and lipoproteins. The presence of outer membrane helps the 
Gram-negative bacteria to maintain the cell structure and act as a permeability barrier 
to large molecules and hydrophobic molecules. The cell wall structures of Gram-
positive and Gram-negative bacteria are shown in the Figure 1.2. 
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        Figure 1.2  Cell wall structures of Gram-negative and Gram-positive bacteria. 
(Source:http://healyourselfathome.com/SUPPORTING_INFORMATION/MICROB    
ES/BACTERIA/ABOUT/BACTERIA_characteristics_gram_pos_or_gram_neg.asp) 
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1.7.1   Bacterial infection 
Most bacteria are free-living species that are harmless and highly beneficial. 
Comparatively there a few species of bacteria that is pathogenic. Pathogenic bacteria 
often form a parasitic coalition with other organisms and obtain most of its 
requirements from those organisms. This parasitic action causes infections and 
diseases to the host. Pathogenic bacteria are a major cause of infectious diseases and 
human death. World Health Organization (WHO) recently estimates that there are 
more infections than people because many people acquire more than one infection 
which are are commonly instigated by streptococci, pneumococci, staphylococci, 
klebsiella  and pseudomonas strains (Braine, 2011). 
 
1.8   Infectious disease 
Infectious diseases caused by bacteria present a massive threat to human life 
worldwide. Infectious diseases have become the second major cause of death 
worldwide and bacteria are the most frequent source of infection-related death. 
Based on worldwide death toll, annually about 12 million people are deceased from 
infections (WHO, 2013). An infection is the invasion and replication of infectious 
bacteria in the host body and the subsequent host tissues response to the presence of 
the pathogen or the toxins they produced in the host. Infectious disease, by contrast, a 
process that destructs a person’s entire health. However, a person whom is infected 
with pathogens does not necessarily have infectious disease. The process when the 
health is not impaired after an infection is called as subclinical infection. According 
to Burt (2004), infectious disease arises when a person’s body lacks natural 
immunity towards the bacterial infection or when the amount of pathogens invading 
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the body exceeds the capability of the host immune system to handle. Pathogenic 
bacteria causes various infectious diseases globally such as tuberculosis, pneumonia, 
tetanus, typhoid fever, meningitis, diphtheria, syphilis, cholera, food borne illness 
and leprosy. Table 1.2 illustrated the list of infectious diseases associated with 
infectious bacteria. 
 
1.9   Pseudomonas aeruginosa  
Pseudomonas aeruginosa is a rod-shaped Gram-negative bacterium and one of the 
leading pathogen causing nosocomial infections worldwide (Tanya and Daniel, 
2009). The high resistance rates of P. aeruginosa are owing to the frequent 
implications in severe infections. P. aeruginosa is an opportunistic pathogen since it 
only infects sick or immunocompromised persons. It rarely causes disease in healthy 
persons and does not ordinarily initiate disease in immunocompromised persons as it 
only multiply freely in them.  
 
Hospitalized patients are highly risky to P. aeruginosa infections as it is often found 
in hospitals. Infections that have been acquired in the hospital are called nosocomial 
diseases. Nosocomial infection is related to any disease contracted by a patient while 
under hospitalization. Nosocomial infections are hospital-acquired infections where 
bacteria resistant to multiple antibiotics exist vastly. Typically, a nosocomial 
infection occurs within 48 hours after admittance to the hospital or within 30 days 
after discharge. People with cystic fibrosis and AIDS frequently die from infections 
produced by P. aeruginosa. Those who have undergone chemotherapy, have had 
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transplants or have any immunosuppressed conditions are far more at risk for 
developing P. aeruginosa infections (Rafla and Tredget, 2011). 
 
The infections triggered by these bacteria are often tough to treat because of the 
intrinsic resistance of the pseudomonal species to many drug classes and its 
capability to acquire further resistance towards β-lactams, aminoglycosides and 
fluoroquinolones via mutation (McGowan, 2006). Multidrug resistance (MDR) is 
now very common and ever-increasing among P. aeruginosa. Numeral strains have 
now been isolated that display resistance to basically all consistent antipseudomonal 
antibiotics. P. aeruginosa is intrinsically resistant  to multiple antibacterial agents 
due to the low outer membrane permeability (Mesaros et al., 2007). 
 
P. aeruginosa has several advantages that makes it a strong opponent. The ability of 
this bacterium to adhere to the host cells, minimal food requirement, multiple 
antibiotic resistancy, rigid cell wall along with outer membrane and capability to 
generate tissue harming proteins empower this bacterium to infect various parts of 
the human body. Infections of P. aeruginosa in specific body sites include heart and 
blood, bones and joints, central nervous system, eye and ear, urinary tract, skin and 
soft tissue and lung. 
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Table 1.2   List of infectious diseases and associated bacterial pathogens. 
Bacteria Diseases 
    
Staphylococcus aureus Skin and wound infection, abscess, toxic shock syndrome 
Streptococcus pneumoniae Pneumonia, otitis, sinusitis 
Escherichia coli Bacteremia, gastrointestinal infection 
Bacillus anthracis  Pulmonary anthrax 
Campylobacter jejuni  Acute enteritis 
Corynebacterium diphtheriae  Diphtheria 
Enterococcus faecalis  Nosocomial infections, urinary tract infection, peritonitis 
Helicobacter pylori  Peptic ulcer 
Leptospira interrogans Leptospirosis 
Mycobacterium leprae  Leprosy  
Mycobacterium tuberculosis Tuberculosis 
Mycoplasma pneumoniae Mycoplasma pneumonia 
Neisseria meningitidis Meningitis 
Pseudomonas aeruginosa Pseudomonas infection, bacteremia 
Salmonella typhi Typhoid fever  
Treponema pallidum Syphilis 
Vibrio cholerae Cholera 
 
(Adapted and modified from O'Connor et al., 2006) 
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1.10   Antibacterial agent 
An antibacterial agent is also termed as an antibiotic. Antibacterial agents are widely 
used either to kill or inhibit the growth of bacteria. These agents are relatively very 
small molecules. Antibiotics are generally categorized based on their chemical 
structure, mechanism of action and spectrum of activity. These chemical agents 
aimed for destructing bacterial growth processes or bacterial functions (Calderon and 
Sabundayo, 2007).  
 
Antibiotics are segregated into two clusters that are bactericidal agent and 
bacteriostatic agent based on their biological activity on bacteria. Bactericidal 
antibiotics kill bacteria meanwhile bacteriostatic antibiotics inhibit bacterial growth. 
Antibiotics with bactericidal effect would target the bacterial cell membrane 
(polymyxins), cell wall (penicillins and cephalosporins) or intervene with bacterial 
enzymes (rifamycins and sulphonamides). Those that obstruct with bacterial protein 
synthesis (tetracyclines and macrolides) are typically bacteriostatic (Sharma et al., 
2002). 
 
Certain antibiotics which act only on specific types of bacteria such as Gram-
negative or Gram-positive bacteria are known to have narrow-spectrum, whereas 
broad spectrum antibiotics target a wide array of bacteria. An ideal antibacterial 
should have the following requirements which includes; selective target, bactericidal, 
narrow spectrum, high therapeutic index, few adverse reactions like toxicity and 
allergy, various routes of administration, good absorption, and good distribution to 
the site of infection and finally emergence of resistance is slow. 
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Many modern antibiotics are derived from the semisynthetic alteration of various 
antibacterial compounds from natural products such as the cephalosporins, 
carbapenems, ketolides and glycylcyclines (Von Nussbaum et al., 2006). It is 
reported that on average, 2 or 3 new antibiotics are being launched every year, but 
the effective life span of any antibiotic is limited to 1 to 2 years due to the emergence 
of antibiotic resistance. 
 
1.11    Cefepime 
Cefepime is a newer cephalosporin (aminothiazolylacetamido) antibiotic with 
broaden spectrum and greater potency than many other cephalosporins (Bonapace, 
1999). This fourth-generation cephalosporin was developed in 1994 and is very 
effective against multiple drug resistant pathogens such as P. aeruginosa and S. 
aureus than third generation agents. Cephalosporins are class of β-lactam antibiotics 
originally derived from fungus Acremonium. Cephalosporins are bactericidal agents 
and possess the same mode of action as other beta-lactam antibiotics such as 
penicillin. This agent disrupts the synthesis of the peptidoglycan layer of bacterial 
cell wall. 
 
Cefepime has extended activity against P. aeruginosa comparable to that of 
ceftazidime. Those strains of P. aeruginosa that have shown resistance to cefotaxime 
and/or ceftazidime are therefore susceptible to cefepime (Fung-Tomc et al., 1991). 
This agent is in a zwitterionic form that can penetrate the outer membrane of Gram- 
negative bacteria. In contrast to other cephalosporins, cefepime more promptly enters 
the Gram-negative bacterial cell hence targets multiple essential penicillin-binding 
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proteins. It exerts the antibacterial activity by appending to specific penicillin-
binding proteins and therefore disrupts the cell wall synthesis. This antibacterial 
agent also capable to escape the effects of many beta-lactamases because of the 
drug’s low affinity for the enzymes. The structure of cefepime is shown in Figure 
1.3. 
 
Cefepime, has a positively charged quaternary nitrogen at the 3-position of the 
cefepime molecule which contribute to the zwitterion characteristics of the molecule. 
In the side chain at the 7-position of the cefepime molecule, a 2-aminothiazolyl-
acetamido group with an alpha-oxyimino substitution augment the stability against 
beta-lactamases by hindering the enzymes' approach to the main nucleus (Yahav et 
al., 2007). Cefepime is not active in vitro against Enterococcus faecalis, Clostridium 
difficile, and methicillin-resistant and cefazolin-resistant S. aureus. The most 
common mechanism of resistance to cefepime is the excess production of beta-
lactamases by pathogens. 
 
Cefepime is generally reserved for treating severe nosocomial pneumonia, as well as 
empirical treatment of febrile neutropenia. It is also often administered for 
complicated urinary tract infections, skin structure infections and intra-abdominal 
infections. In neutropenic patients, cefepime alone reduces fever as effectively as 
combination of antibacterial agents such as ceftazidime or piperacillin plus 
gentamicin (Chapman and Perry, 2003). For life-threatening infections, the dosage of 
cefepime proposed is 1000-2000 mg i.v. every 8-24 hours and for severe infections, 
the dosage of cefepime is 500-2000 mg i.v. every 12-24 hours. 
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 Figure 1.3   Chemical structure of cefepime. 
 (Source:http://pubchem.ncbi.nlm.nih.gov/compound/cefepime#section= 
   Related-Compounds-with-Annotation) 
 
 
1.12   Mechanism of action of antibacterial agents 
Antibacterial agents operate by precluding crucial life sustaining processes in the 
bacteria such as the synthesis of cell wall material, the synthesis of DNA, RNA, 
ribosomes and proteins. The mode of action of antibiotics depends on the nature of 
their structure and degree of affinity towards target sites in bacterial cells. Inhibition 
of bacterial cell wall synthesis by antibacterial agent is very selective because cells of 
humans and animals do not have cell wall. The cell wall structure is vital for the life 
and survival of bacterial species. Antibiotics that aimed at cell walls can therefore 
selectively kill or inhibit bacteria. Examples of cell wall inhibitors are 
cephalosporins, penicillins, vancomycin and bacitracin. 
 
Inhibition of cellular membrane function by antibiotics is frequently poorly selective 
and can be toxic for systemic use in the mammalian host. This is because cell 
membranes are found in both eukaryotic and prokaryotic cells. Membrane structure 
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is an essential partition that segregates and regulates the intra and extracellular flow 
of substances. A break or impairment to this structure could give rise to leakage of 
important solutes crucial for the cell survival. Therefore, clinical usage of this class 
of antibiotic is limited to topical applications. Examples of cellular membrane 
inhibitors are polymixin B and colistin. 
 
Protein synthesis is a vital process compulsory for the multiplication and survival of 
all bacterial cells. All the cellular structures and enzymes are fundamentally made of 
proteins. Inhibition of protein synthesis by antibacterial agents targets the binding 
sites of either the 30S or 50S subunits of the intracellular ribosome. This action 
interrupts the normal cellular metabolism of the bacteria and consequently leads to 
the death of the organism or the inhibition of its growth and multiplication.  
Examples of protein synthesis inhibitors are chloramphenicol, tetracyclines, 
aminoglycosides, macrolides, lincosamides and streptogramins. 
 
All living forms including bacteria require DNA and RNA for the replication 
processes. Inhibition of nucleic acid synthesis involves the binding process of 
antibacterial agent to the mechanism components involved in the process of DNA or 
RNA synthesis. This exploitation result in intrusion of the normal cellular processes 
which will influence bacterial multiplication and survival. Examples of nucleic acid 
synthesis inhibitors are rifampin, metronidazole and quinolones. 
 
 
